These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32398334)

  • 1. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009.
    Benea C; Turner KA; Roseman M; Bero LA; Lexchin J; Turner EH; Thombs BD
    Syst Rev; 2020 Apr; 9(1):77. PubMed ID: 32268911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study.
    Roseman M; Turner EH; Lexchin J; Coyne JC; Bero LA; Thombs BD
    BMJ; 2012 Aug; 345():e5155. PubMed ID: 22906823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
    Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
    J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-declared stock ownership and association with positive trial outcome in randomized controlled trials with binary outcomes published in general medical journals: a cross-sectional study.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Jul; 18(1):354. PubMed ID: 28747226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.
    Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Boscardin WJ; Keyhani S
    BMJ; 2017 Jan; 356():i6770. PubMed ID: 28096109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
    Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
    Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.
    Roper N; Korenstein D
    J Gen Intern Med; 2015 Oct; 30(10):1421-5. PubMed ID: 25832619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.
    Rose SL; Krzyzanowska MK; Joffe S
    J Clin Oncol; 2010 Mar; 28(8):1316-21. PubMed ID: 20065190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):MR000040. PubMed ID: 33289919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs.
    Tibau A; Bedard PL; Srikanthan A; Ethier JL; Vera-Badillo FE; Templeton AJ; Ocaña A; Seruga B; Barnadas A; Amir E
    J Clin Oncol; 2015 Jan; 33(1):100-6. PubMed ID: 25385736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression.
    Froud R; Bjørkli T; Bright P; Rajendran D; Buchbinder R; Underwood M; Evans D; Eldridge S
    BMC Musculoskelet Disord; 2015 Nov; 16():370. PubMed ID: 26620449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey.
    Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA
    J Clin Epidemiol; 2017 Jul; 87():78-86. PubMed ID: 28412465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting conflicts of interest in randomised trials of patient blood management interventions in patients requiring major surgery: a systematic review and meta-analysis.
    Roman M; Fashina O; Tomassini S; Abbasciano RG; Lai F; Richards T; Murphy G
    BMJ Open; 2022 Aug; 12(8):e054582. PubMed ID: 35977767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
    Lundh A; Krogsbøll LT; Gøtzsche PC
    Trials; 2012 Aug; 13():146. PubMed ID: 22920226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews and meta-analyses on psoriasis: role of funding sources, conflict of interest and bibliometric indices as predictors of methodological quality.
    Gómez-García F; Ruano J; Aguilar-Luque M; Gay-Mimbrera J; Maestre-Lopez B; Sanz-Cabanillas JL; Carmona-Fernández PJ; González-Padilla M; Vélez García-Nieto A; Isla-Tejera B
    Br J Dermatol; 2017 Jun; 176(6):1633-1644. PubMed ID: 28192600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial.
    Buffel du Vaure C; Boutron I; Perrodeau E; Ravaud P
    BMC Med; 2014 Apr; 12():69. PubMed ID: 24779384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.